| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2006;81:1028-1032
© 2006 The Society of Thoracic Surgeons
Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan
Accepted for publication September 30, 2005.
* Address correspondence to Dr Okada, Department of Thoracic Surgery, Hyogo Medical Center for Adults, Kitaohji-cho, 13-70, Akashi City 673-8558, Hyogo, Japan (Email: morihito1217jp{at}aol.com).
BACKGROUND: Improved radiologic imaging provides earlier detection of non–small cell lung cancer, but controversy exists regarding the need for complete lymph node dissection. This study was designed to evaluate the possibility of lesser mediastinal dissection for early-stage lung cancer.
METHODS: Selective mediastinal dissection is defined as follows: Dissection of the upper mediastinum for upper-lobe tumors is performed but it is not needed for lower-lobe tumors with intact hilar and lower mediastinal nodes. Also, dissection of the lower mediastinum for an upper-lobe tumor is not routinely required when the nodes in the hilum and upper mediastinum are negative. From 1997 through 2002, 377 patients with clinico-surgical stage I non–small cell lung cancer underwent curative-intent surgery with selective dissection (group S). In addition, 358 patients with the same-stage disease who underwent complete lymphadenectomy by the same surgical team served as historic controls (group C).
RESULTS: The characteristics of the two groups were well balanced. There was no significant difference in disease-free survival (p = 0.376) or overall survival (p = 0.060). Multivariate analysis showed that the dissection mode did not significantly influence either disease-free survival (p = 0.636) or overall survival (p = 0.119). The postoperative morbidity rates were 17.3% and 10.1% for group C and group S, respectively (p = 0.005). One operative death occurred in each group (0.3%). The rates of distant metastasis and local recurrence were similar in the two groups.
CONCLUSIONS: Selective mediastinal dissection for clinico-surgical stage I non–small cell lung cancer proved to be as effective as complete dissection, and although large multicenter trials are warranted, it might be considered as an alternative for curative surgery in this era of minimally invasive surgery.
This article has been cited by other articles:
|
|
 |
|
  H. Matsuguma, I. Oki, R. Nakahara, N. Ohata, S. Igarashi, K. Mori, S. Endo, and K. Yokoi Proposal of new nodal classifications for non-small-cell lung cancer based on the number and ratio of metastatic lymph nodes Eur J Cardiothorac Surg, January 1, 2012; 41(1): 19 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Hughes, M. F. Chowdhry, S. M. Woolley, and W. S. Walker In patients undergoing lung resection for non-small cell lung cancer, is lymph node dissection or sampling superior? Interact CardioVasc Thorac Surg, September 1, 2011; 13(3): 311 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. D'Amico, J. Niland, R. Mamet, C. Zornosa, E. U. Dexter, and M. W. Onaitis Efficacy of Mediastinal Lymph Node Dissection During Lobectomy for Lung Cancer by Thoracoscopy and Thoracotomy Ann. Thorac. Surg., July 1, 2011; 92(1): 226 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ichinose, T. Kohno, S. Fujimori, and M. Mun Locoregional Control of Thoracoscopic Lobectomy With Selective Lymphadenectomy for Lung Cancer Ann. Thorac. Surg., July 1, 2010; 90(1): 235 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Okasaka, N. Usami, T. Taniguchi, K. Kawaguchi, T. Okagawa, H. Suzuki, K. Matsuo, and K. Yokoi Can non-performance of radical systematic mediastinal lymphadenectomy be justified in elderly lung cancer patients? An evaluation using propensity-based survival analysis Eur J Cardiothorac Surg, July 1, 2010; 38(1): 27 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ishiguro, K. Matsuo, T. Fukui, S. Mori, S. Hatooka, and T. Mitsudomi Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: A large-scale retrospective cohort study applying a propensity score J. Thorac. Cardiovasc. Surg., April 1, 2010; 139(4): 1001 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-P. Hsu, J.-Y. Hsia, G.-C. Chang, C.-Y. Chuang, S.-E. Shai, S.-S. Yang, M.-C. Lee, and P.-C. Kwan Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 426 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Moffatt-Bruce, S. P. Povoski, S. Sharif, N. C. Hall, P. Ross Jr, M. A. Johnson, and E. W. Martin Jr A Novel Approach to Positron Emission Tomography in Lung Cancer Ann. Thorac. Surg., October 1, 2008; 86(4): 1355 - 1357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Whitson, S. S. Groth, and M. A. Maddaus Surgical Assessment and Intraoperative Management of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 2007; 84(3): 1059 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kuzdzal, M. Zielinski, B. Papla, A. Urbanik, W. Wojciechowski, M. Narski, A. Szlubowski, and L. Hauer The transcervical extended mediastinal lymphadenectomy versus cervical mediastinoscopy in non-small cell lung cancer staging Eur J Cardiothorac Surg, January 1, 2007; 31(1): 88 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fukuse Invited commentary Ann. Thorac. Surg., March 1, 2006; 81(3): 1033 - 1033. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
